Standards & Regulations

Apr 01, 2002
Pharmaceutical Technology
Proposed funding increases for FDA reflect plans to significantly increase user fees collected from manufacturers under the Presciption Drug User Fee Act.
Mar 01, 2002
Pharmaceutical Technology
FDA wants manufacturers to revise product labeling and packaging and step up adverse-event monitoring to reduce risky product use.
Feb 01, 2002
Pharmaceutical Technology
FDA's Center for Drug Evaluation and Research is driving efforts toward creating initiatives to streamline regulatory processes, speed up drug production, and reduce costs.
Jan 01, 2002
Pharmaceutical Technology
Pharmaceutical companies will face a number of issues and challenges this year that will affect their resources, operations, and the markets they serve.
Dec 02, 2001
Pharmaceutical Technology
Anthrax contamination has put pharmaceutical quality and supply issues on the front page, along with patent and pricing policies.
Nov 02, 2001
Pharmaceutical Technology
Threats of bioterrorism generate new reulatory policies to protect the public against biological warfare.
Oct 02, 2001
Pharmaceutical Technology
FDA may adopt new requirements to enhance the safe use of pharmaceuticals and ensure that all US drugs are available when needed.
Sep 02, 2001
Pharmaceutical Technology
Providing prescription drug benefits for senior citizens is a pressing issue for Congress, pharmaceutical manufacturers, pharmacies, and ultimately the beneficiaries of proposed plans.
Aug 02, 2001
Pharmaceutical Technology
The Center for Drug Evaluation and Research is adopting new approaches to how it oversees the development and approval of new drugs and how it ensures the safe use of prescription drugs by the public.
Jul 01, 2001
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Appropriate sampling procedures, proper preparation, and correct instrumental parameters may yield differing, but correct, results.
native1_300x100
lorem ipsum